Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients.

Cancers (Basel) · 2019 · PMC6356815 · PMID 30650521

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A decrease in the amount of mutant KRAS ctDNA during or after the first cycle of chemotherapy showed a trend towards a better disease control rate (CR+PR+SD) as shown on the first radiologic evaluation scan.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.